Roswell Park promotes four physicians to leadership roles
Click Here to Manage Email Alerts
Roswell Park Comprehensive Cancer Center has promoted four physicians to leadership roles in its clinical research program.
Saby George, MD, FACP, has been named director of network clinical trials. George will serve as the primary liaison between Roswell Park’s Office of Clinical Research and the Roswell Park Care Network for the development and implementation of clinical trials at network sites.
Ellis Levine, MD, has been appointed director of academic affairs for clinical investigations. Levine will support investigator-initiated and cooperative group clinical trials, focusing on resource allocation and prioritization.
Tong Dai, MD, PhD, has been promoted to associate director for solid tumor studies. Dai — whose specialties include treatment of gastrointestinal and head and neck cancers — will oversee, develop and provide guidance on new development of early-phase solid tumor protocols.
Elizabeth Griffiths, MD, has been named associate director for liquid tumor studies. She will serve as clinical disease team leader for early targeted therapy trials for hematologic tumors, and she will direct all early-phase liquid tumor clinical trials. Griffiths, a HemOnc Today Next Gen Innovator, will continue to serve as director of myelodysplastic syndrome therapeutics and co-lead Roswell Park’s young adult program.
“These talented physicians are all leaders in their respective fields and will continue to drive innovative and exciting work in cancer research,” Igor Puzanov, MD, MSCI, FACP, senior vice president for clinical investigation and director of the Center for Early Phase Clinical Trials at Roswell Park, said in a press release. “I look forward to the care our team will provide for our patients guided by their insights and ideas.”
Click Here to Manage Email Alerts